GlaxoSmithKline plans to launch its Lucozade energy drink in the US as the healthcare giant looks to reduce the brand’s reliance on the UK market.
US: GSK to launch Lucozade in the US
GlaxoSmithKline plans to launch its Lucozade energy drink in the US as the healthcare giant looks to reduce the brand's reliance on the UK market.